Vitamin D levels do not cause vitamin-drug interactions with dexamethasone or dasatinib in mice
Vitamin D3 (VD3) induces intestinal CYP3A that metabolizes orally administered anti-leukemic chemotherapeutic substrates dexamethasone (DEX) and dasatinib potentially causing a vitamin-drug interaction. To determine the impact of VD3 status on systemic exposure and efficacy of these chemotherapeutic...
Main Authors: | Kavya Annu, Kazuto Yasuda, William V. Caufield, Burgess B. Freeman, Erin G. Schuetz |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528301/?tool=EBI |
Similar Items
-
Effects of vitamin A combined with dexamethasone on airway epithelium structure and function in asthmatic mice
by: HU Jie, et al.
Published: (2019-11-01) -
Herb-drug interaction: Effect of sinapic acid on the pharmacokinetics of dasatinib in rats
by: Mudassar Shahid, et al.
Published: (2023-11-01) -
A strange cause of chylothorax- Dasatinib induced
by: M Natraj, et al.
Published: (2018-01-01) -
Vitamin A Status in Preterm Infants Is Associated with Inflammation and Dexamethasone Exposure
by: Madelaine Eloranta Rossholt, et al.
Published: (2023-01-01) -
Pharmacokinetics of Dasatinib
by: Jana Hořínková, et al.
Published: (2019-10-01)